Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ON SEMICONDUCTOR CORPON · Entity 3161 | Director · CEO & President | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ON SEMICONDUCTOR CORP
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 1,054,123 |
Ending reported balance
After 2026-02-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 75,315 · Balance 1,090,925 F1: Represents time-based restricted stock units that will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting date. Row 2 · 2026-02-21 · Tax withholding · Disposed 36,802 · Balance 1,054,123 F2: Represents shares withheld to cover taxes due upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents time-based restricted stock units that will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting date.
F2: Represents shares withheld to cover taxes due upon the vesting of restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CYPRESS SEMICONDUCTOR CORP /DE/
Report date April 16, 2020 · Filed April 17, 2020
Section 16 reporting ended · disclosed 2020-04-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 1
1 source rowRow 1 · 2020-04-16 · Disposition to issuer · Disposed 671,989 · Balance 0 F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-04-16 · Disposition to issuer · Disposed 32,198 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F3: On February 16, 2018, the Reporting Person was granted 96,594 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-04-16 · Disposition to issuer · Disposed 73,134 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F5: On February 15, 2019, the Reporting Person was granted 146,268 restricted stock units, with approximately 50% of the units vesting on the first anniversary of the grant date and the remainder of the units vesting in equal installments on the second and third anniversaries of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-04-16 · Disposition to issuer · Disposed 233,867 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F6: On March 1, 2020, the Reporting Person was granted 233,867 restricted stock units that vest in three equal annual installments beginning on February 14, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest.
F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement.
F3: On February 16, 2018, the Reporting Person was granted 96,594 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement.
F5: On February 15, 2019, the Reporting Person was granted 146,268 restricted stock units, with approximately 50% of the units vesting on the first anniversary of the grant date and the remainder of the units vesting in equal installments on the second and third anniversaries of the grant date.
F6: On March 1, 2020, the Reporting Person was granted 233,867 restricted stock units that vest in three equal annual installments beginning on February 14, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2019 Filed Feb 13, 2019 18:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009844 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 18:32 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 105,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007010 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,859 Underlying: Common Stock · 105,718 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On March 16, 2017, the Reporting Person was granted 158,577 service-based RSUs, with two-thirds (2/3) of the RSUs scheduled to vest on February 1, 2019 and the remaining one-third (1/3) scheduled to vest on February 3, 2020. F3 · derivative.expiration_date: On March 16, 2017, the Reporting Person was granted 158,577 service-based RSUs, with two-thirds (2/3) of the RSUs scheduled to vest on February 1, 2019 and the remaining one-third (1/3) scheduled to vest on February 3, 2020. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 18:32 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 35,042 | $14.79 | $518,271.18 |
DisclosureSEC source: 0001209191-19-007010 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,753 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 18:32 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 105,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007010 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 16:06 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionStock Option (right to buy) · Derivative | 4,300 | $0.00 Strike: $6.17 | $0.00 |
DisclosureSEC source: 0001209191-19-003241 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,300 shares Expires 2019-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The option was granted on March 19, 2009 and vested in 60 equal monthly installments over five years. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 16:06 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | SaleCommon Stock | 4,300 | $13.00 | $55,900.00 |
DisclosureSEC source: 0001209191-19-003241 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,077 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 16:06 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 4,300 | $6.17 | $26,531.00 |
DisclosureSEC source: 0001209191-19-003241 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes an additional 1,538 shares acquired under the Issuer's employee stock purchase plan. Read SEC document |
| November 29, 2018 Filed Nov 29, 2018 16:46 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | SaleCommon Stock | 25,000 | $13.87 | $346,747.50 |
DisclosureSEC source: 0001209191-18-060260 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,539 F2 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.75 to $13.9479 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 16:46 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | SaleCommon Stock | 25,000 | $13.89 | $347,172.50 |
DisclosureSEC source: 0001209191-18-060260 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,539 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.84 to $13.9357 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 10, 2018 Filed Nov 14, 2018 16:07 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-058503 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,212 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant vests quarterly in equal installments over three years beginning on November 10, 2016. F4 · derivative.expiration_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant vests quarterly in equal installments over three years beginning on November 10, 2016. Read SEC document |
| November 10, 2018 Filed Nov 14, 2018 16:07 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 7,242 | $13.22 | $95,739.24 |
DisclosureSEC source: 0001209191-18-058503 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,539 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 10, 2018 Filed Nov 14, 2018 16:07 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-058503 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · balance_after: Includes 1,832 shares acquired under the Issuer's employee stock purchase plan on June 29, 2018. Read SEC document |
| August 10, 2018 Filed Aug 10, 2018 18:25 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046306 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,616 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant vests quarterly in equal installments over three years beginning on November 10, 2016. F4 · derivative.expiration_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant vests quarterly in equal installments over three years beginning on November 10, 2016. Read SEC document |
| August 10, 2018 Filed Aug 10, 2018 18:25 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 7,242 | $16.71 | $121,013.82 |
DisclosureSEC source: 0001209191-18-046306 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,545 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 10, 2018 Filed Aug 10, 2018 18:25 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046306 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · balance_after: Since the date of the Reporting Person's last ownership report, he transferred 1,056 shares of Issuer common stock to his former spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse. Read SEC document |
| June 27, 2018 Filed Jun 28, 2018 16:10 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionStock Option (right to buy) · Derivative | 1,339 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001209191-18-039839 · doc4.xml · derivative · entry 4 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,339 shares Expires 2018-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on November 20, 2008 and vested in 60 equal monthly installments over five years. Read SEC document |
| June 27, 2018 Filed Jun 28, 2018 16:10 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionStock Option (right to buy) · Derivative | 2,472 | $0.00 Strike: $5.55 | $0.00 |
DisclosureSEC source: 0001209191-18-039839 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,472 shares Expires 2018-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on July 8, 2008 and vested in 60 equal monthly installments over five years. Read SEC document |
| June 27, 2018 Filed Jun 28, 2018 16:10 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 1,339 | $2.72 | $3,642.08 |
DisclosureSEC source: 0001209191-18-039839 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2018 Filed Jun 28, 2018 16:10 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 2,472 | $5.55 | $13,715.15 |
DisclosureSEC source: 0001209191-18-039839 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 14, 2018 20:40 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 9,125 | $16.39 | $149,513.13 |
DisclosureSEC source: 0001209191-18-030092 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,628 Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:40 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030092 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,020 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant vests quarterly in equal installments over three years beginning on November 10, 2016. F2 · derivative.expiration_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant vests quarterly in equal installments over three years beginning on November 10, 2016. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:40 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030092 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| April 30, 2018 Filed May 2, 2018 07:00 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | PurchaseCommon Stock | 10,000 | $15.03 | $150,268.00 |
DisclosureSEC source: 0001209191-18-027223 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,349 F1 · kind: The Reporting Person's purchase of Issuer common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 10,000 shares, with the Reporting Person's sale of 43,991 shares of Issuer common stock at a weighted average sales price of $17.5957 per share on February 28, 2018. The Reporting Person has agreed to pay to the Issuer $26,545.13, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs. F2 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.016 to $15.0375 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 20:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 56,287 | $17.10 | $962,507.70 |
DisclosureSEC source: 0001209191-18-016063 · doc4.xml · nonDerivative · entry 7 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,349 F7 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.10 to $17.105 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 20:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 3,009 | $17.10 | $51,453.90 |
DisclosureSEC source: 0001209191-18-016063 · doc4.xml · nonDerivative · entry 5 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,651 F7 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.10 to $17.105 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 20:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 16,607 | $17.10 | $283,979.70 |
DisclosureSEC source: 0001209191-18-016063 · doc4.xml · nonDerivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,720 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 110,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016063 · doc4.xml · nonDerivative · entry 6 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the March 16, 2017 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program. F5 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 5,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016063 · doc4.xml · nonDerivative · entry 4 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the April 1, 2016 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program. F5 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 32,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016063 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the March 3, 2015 grant awarded under the Issuer's 2013 Stock Plan (the "Stock Plan") as part of the Issuer's Performance Based Accelerated Restricted Stock Program (the "PARS Program"). F5 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | SaleCommon Stock | 43,991 | $17.60 | $774,052.44 |
DisclosureSEC source: 0001209191-18-016063 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,567 F1 · kind: The sale of these shares was subsequent to and a separate transaction from the transfer of shares that was pursuant to the domestic relations order referenced in footnote 3 to this Form 4. F2 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.405 to $17.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · balance_after: Since the date of the Reporting Person's last ownership report, he transferred 149,126 shares of Issuer common stock to his former spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 17:46 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 96,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-012053 · doc4.xml · derivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,594 Underlying: Common Stock · 96,594 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On February 16, 2018, the Reporting Person was granted 96,594 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On February 16, 2018, the Reporting Person was granted 96,594 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 20:49 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 9,003 | $15.61 | $140,566.54 |
DisclosureSEC source: 0001209191-18-009829 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,684 Read SEC document |
| February 10, 2018 Filed Feb 13, 2018 20:49 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-009829 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,424 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. F2 · derivative.expiration_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. Read SEC document |
| February 10, 2018 Filed Feb 13, 2018 20:49 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-009829 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 12,842 | $16.20 | $208,041.68 |
DisclosureSEC source: 0001209191-18-007942 · doc4.xml · nonDerivative · entry 4 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,283 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.20 to $16.205 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 11,361 | $16.20 | $184,082.28 |
DisclosureSEC source: 0001209191-18-007942 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,125 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.20 to $16.211 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 33,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007942 · doc4.xml · derivative · entry 6 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F5 · derivative.exercise_date: On April 1, 2016, the Reporting Person was granted 33,000 service based RSUs, vesting in one annual installment on February 2, 2018. F5 · derivative.expiration_date: On April 1, 2016, the Reporting Person was granted 33,000 service based RSUs, vesting in one annual installment on February 2, 2018. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007942 · doc4.xml · derivative · entry 5 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: On March 3, 2015, the Reporting Person was granted 90,000 service based RSUs, vesting in three equal annual installments beginning on January 29, 2016. F4 · derivative.expiration_date: On March 3, 2015, the Reporting Person was granted 90,000 service based RSUs, vesting in three equal annual installments beginning on January 29, 2016. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 33,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007942 · doc4.xml · nonDerivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007942 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 20:22 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 9,635 | $16.94 | $163,229.43 |
DisclosureSEC source: 0001209191-17-060755 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,486 F2 · shares: Represents the aggregate number of shares of common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. F3 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.9407 to $16.945 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:22 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-060755 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,828 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. F4 · derivative.expiration_date: On August 10, 2016, the Reporting Person was granted 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:22 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-060755 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 21:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 9,633 | $13.22 | $127,352.11 |
DisclosureSEC source: 0001209191-17-048824 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,717 F2 · shares: The sales reported in this Form 4 represent the aggregate number of shares of Issuer common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. F2 · price: The sales reported in this Form 4 represent the aggregate number of shares of Issuer common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 21:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048824 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,232 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. F3 · derivative.expiration_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 21:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048824 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 17:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionStock Option (right to buy) · Derivative | 4,450 | $10.47 Strike: $10.47 | $46,591.50 |
DisclosureSEC source: 0001209191-17-047447 · doc4.xml · derivative · entry 5 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The option was granted on August 10, 2009 and was fully vested on June 1, 2014. The option was due to expire on August 10, 2017. F4 · derivative.exercise_date: The option was granted on August 10, 2009 and was fully vested on June 1, 2014. The option was due to expire on August 10, 2017. F4 · derivative.expiration_date: The option was granted on August 10, 2009 and was fully vested on June 1, 2014. The option was due to expire on August 10, 2017. Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 17:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionStock Option (right to buy) · Derivative | 927 | $6.70 Strike: $6.70 | $6,207.38 |
DisclosureSEC source: 0001209191-17-047447 · doc4.xml · derivative · entry 4 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The option was granted on August 8, 2007 and was fully vested on July 16, 2012. The option was due to expire on August 8, 2017. F3 · derivative.exercise_date: The option was granted on August 8, 2007 and was fully vested on July 16, 2012. The option was due to expire on August 8, 2017. F3 · derivative.expiration_date: The option was granted on August 8, 2007 and was fully vested on July 16, 2012. The option was due to expire on August 8, 2017. Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 17:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 4,767 | $14.24 | $67,873.02 |
DisclosureSEC source: 0001209191-17-047447 · doc4.xml · nonDerivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,946 F1 · shares: Represents the aggregate number of shares of Issuer common stock withheld for payment of the exercise price and tax liability incident to the transactions of a security issued in accordance with Rule 16b-3. F2 · price: The price reported in Column 4 is a weighted average price. 4,667 shares were sold at a price of $14.2382 per share and 100 shares were sold at a price of $14.235 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 17:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 4,450 | $10.47 | $46,591.50 |
DisclosureSEC source: 0001209191-17-047447 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.